Risperidone versus other atypical antipsychotic medication for schizophrenia
β Scribed by William T. Carpenter
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 56 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1523-3812
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to longβacting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirtyβsix patients with schizophrenia treated with oral
## Abstract ## Objective Although the evidence base for the use of antipsychotics in older people with schizophrenia is generally of low quality, it tends to support the use of atypical antipsychotics. Only limited information regarding longer term adherence to these apparently more effective drug